Home › Compare › DRVYF vs JNJ

DRVYF vs JNJ: Dividend Comparison 2026

DRVYF yields 20000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DRVYF wins by $52481917574412746752.00M in total portfolio value
10 years
DRVYF
DRVYF
● Live price
20000.00%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$52481917574412746752.00M
Annual income
$51,970,745,957,167,775,000,000,000.00
Full DRVYF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — DRVYF vs JNJ

📍 DRVYF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDRVYFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DRVYF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
DRVYF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DRVYF
Annual income on $10K today (after 15% tax)
$1,700,000.00/yr
After 10yr DRIP, annual income (after tax)
$44,175,134,063,592,610,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, DRVYF beats the other by $44,175,134,063,592,610,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DRVYF + JNJ for your $10,000?

DRVYF: 50%JNJ: 50%
100% JNJ50/50100% DRVYF
Portfolio after 10yr
$26240958787206373376.00M
Annual income
$25,985,372,978,583,888,000,000,000.00/yr
Blended yield
99.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DRVYF
No analyst data
Altman Z
-46.9
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DRVYF buys
0
JNJ buys
0
No recent congressional trades found for DRVYF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDRVYFJNJ
Forward yield20000.00% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$52481917574412746752.00M ✓$20.0K
Annual income after 10y$51,970,745,957,167,775,000,000,000.00 ✓$827.78
Total dividends collected$52448189483771600896.00M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DRVYF vs JNJ ($10,000, DRIP)

YearDRVYF PortfolioDRVYF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$2,010,700$2,000,000.00$10,676$355.77+$2.00M → DRVYF
2$377,983,225$375,831,775.70$11,407$389.39+$377.97M → DRVYF
3$66,433,479,469$66,029,037,418.28$12,198$426.53+$66433.47M → DRVYF
4$10,916,985,471,987$10,845,901,648,955.73$13,056$467.62+$10916985.46M → DRVYF
5$1,677,384,363,769,318$1,665,703,189,314,291.80$13,987$513.12+$1677384363.76M → DRVYF
6$240,985,175,079,139,100$239,190,373,809,905,920.00$14,998$563.56+$240985175079.12M → DRVYF
7$32,373,573,631,143,694,000$32,115,719,493,809,017,000.00$16,098$619.52+$32373573631143.68M → DRVYF
8$4,066,766,648,320,630,000,000$4,032,126,924,535,306,000,000.00$17,295$681.69+$4066766648320630.00M → DRVYF
9$477,730,483,406,513,300,000,000$473,379,043,092,810,300,000,000.00$18,599$750.82+$477730483406513344.00M → DRVYF
10$52,481,917,574,412,750,000,000,000$51,970,745,957,167,775,000,000,000.00$20,022$827.78+$52481917574412746752.00M → DRVYF

DRVYF vs JNJ: Complete Analysis 2026

DRVYF — Stock

Discovery Alaska Limited engages in mineral exploration activities in Western Australia. The company primarily explores for lithium, tin, silver, gold, and copper deposits. It holds 100% interest in Chulitna project comprising 308 mining claims covering 199.4 square kilometers located in the state of Alaska public lands. The company was formerly known as Discovery Africa Limited and changed its name to Discovery Alaska Limited in December 2021. Discovery Alaska Limited was incorporated in 2010 and is based in Osborne Park, Australia.

Full DRVYF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this DRVYF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DRVYF vs SCHDDRVYF vs JEPIDRVYF vs ODRVYF vs KODRVYF vs MAINDRVYF vs ABBVDRVYF vs MRKDRVYF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.